Bristol Myers Squibb reports $48.19 billion revenue for fiscal year ended December 31, 2025, down 0.2%
Bristol Myers Squibb reported revenue of $48.19 billion for the year ended December 31, 2025, a decrease of 0.2% from the previous year ($48.3 billion).
For the same period it posted net income of $7.05 billion, or $3.46 per diluted share (-4.41 a year earlier).
That is a net margin of 14.6%.
On Sanad's AAOIFI Standard 21 screen, Bristol Myers Squibb is currently not compliant: interest-bearing debt is 34.8% of market capitalisation (limit 30%), and impure income is 1.2% of revenue (limit 5%).
Is Bristol Myers Squibb halal?
See the full AAOIFI screening of Bristol Myers Squibb
See the full AAOIFI screening of Bristol Myers Squibb
Source: 10-K filed with the U.S. Securities and Exchange Commission on February 11, 2026. View the filing. Figures are as reported in the filing. This is information, not investment advice.